Are BSL-3(+) conditions enough, or should experiments with 1918 influenza be done at BSL-4 containment?
2
What are the responsibilities of the researchers who conduct, the journals who publish, and the bodies who approve experiments with dual-use implications in communicating the risks and benefits to the public?
3
Should there be limits on publication of genome sequences of pathogens or methods that could be used to make them?
4
What types of biological research should be classified and who should decide?
5
How extensively should research with dual-use implications be reviewed before it is published?
6
What do you think of the response by the editor of Science that even if the NSABB had recommended the article not be published, that he would have anyway?
